• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

90Y微球放射性栓塞:血管造影及技术考量

Radioembolization with 90Y microspheres: angiographic and technical considerations.

作者信息

Lewandowski Robert J, Sato Kent T, Atassi Bassel, Ryu Robert K, Nemcek Albert A, Kulik Laura, Geschwind Jean-Francois, Murthy Ravi, Rilling William, Liu David, Bester Lourens, Bilbao Jose Ignacio, Kennedy Andrew S, Omary Reed A, Salem Riad

机构信息

Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.

出版信息

Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):571-92. doi: 10.1007/s00270-007-9064-z. Epub 2007 May 22.

DOI:10.1007/s00270-007-9064-z
PMID:17516113
Abstract

The anatomy of the mesenteric system and the hepatic arterial bed has been demonstrated to have a high degree of variation. This is important when considering pre-surgical planning, catheterization, and trans-arterial hepatic therapies. Although anatomical variants have been well described, the characterization and understanding of regional hepatic perfusion in the context of radioembolization have not been studied with great depth. The purpose of this review is to provide a thorough discussion and detailed presentation of the angiographic and technical aspects of radioembolization. Normal vascular anatomy, commonly encountered variants, and factors involved in changes to regional perfusion in the presence of liver tumors are discussed. Furthermore, the principles described here apply to all liver-directed transarterial therapies.

摘要

肠系膜系统和肝动脉床的解剖结构已被证明具有高度变异性。这在考虑术前规划、导管插入术和经动脉肝治疗时很重要。尽管解剖变异已得到充分描述,但在放射性栓塞背景下对区域肝灌注的特征和理解尚未得到深入研究。本综述的目的是对放射性栓塞的血管造影和技术方面进行全面讨论并详细介绍。讨论了正常血管解剖、常见变异以及存在肝肿瘤时区域灌注变化所涉及的因素。此外,这里描述的原则适用于所有肝靶向经动脉治疗。

相似文献

1
Radioembolization with 90Y microspheres: angiographic and technical considerations.90Y微球放射性栓塞:血管造影及技术考量
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):571-92. doi: 10.1007/s00270-007-9064-z. Epub 2007 May 22.
2
Technical aspects of radioembolization with 90Y microspheres.90Y微球放射性栓塞的技术层面
Tech Vasc Interv Radiol. 2007 Mar;10(1):12-29. doi: 10.1053/j.tvir.2007.08.001.
3
Angiographic considerations in patients undergoing liver-directed radioembolization with 90Y microspheres.接受钇-90微球肝脏靶向放射性栓塞治疗患者的血管造影考量
Acta Gastroenterol Belg. 2010 Oct-Dec;73(4):489-96.
4
Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries.肝肿瘤的放射性栓塞:肝内动脉闭塞后的血流重新分布
Rofo. 2011 Nov;183(11):1058-64. doi: 10.1055/s-0031-1281767. Epub 2011 Sep 28.
5
[Radioembolization with (90)Y-microspheres for liver tumors].[钇-90微球放射性栓塞治疗肝肿瘤]
Rev Esp Med Nucl Imagen Mol. 2015 Jul-Aug;34(4):244-57. doi: 10.1016/j.remn.2015.03.004. Epub 2015 Apr 22.
6
The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.导管导向CT血管造影对肝细胞癌钇-90放射性栓塞治疗的影响。
J Vasc Interv Radiol. 2005 Aug;16(8):1085-91. doi: 10.1097/01.RVI.0000177063.92678.21.
7
Angiographic considerations in patients undergoing liver-directed therapy.接受肝脏定向治疗患者的血管造影考量
J Vasc Interv Radiol. 2005 Jul;16(7):911-35. doi: 10.1097/01.RVI.0000164324.79242.B2.
8
Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.钇-90 树脂微球选择性内放射治疗的患者选择和活动计划指南。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):401-7. doi: 10.1016/j.ijrobp.2010.08.015. Epub 2010 Oct 13.
9
Invited commentary.特邀评论。
J Vasc Interv Radiol. 2011 Oct;22(10):1362-3. doi: 10.1016/j.jvir.2011.07.013.
10
Radioembolization with yttrium-90 microspheres work up: Practical approach and literature review.钇-90微球放射性栓塞治疗的评估:实用方法与文献综述
Diagn Interv Imaging. 2015 Jun;96(6):547-62. doi: 10.1016/j.diii.2014.03.014. Epub 2014 Apr 26.

引用本文的文献

1
Subtraction of single-photon emission computed tomography (SPECT) in radioembolization: a comparison of four methods.放射性栓塞术中单光子发射计算机断层扫描(SPECT)的减法:四种方法的比较。
EJNMMI Phys. 2024 Aug 15;11(1):72. doi: 10.1186/s40658-024-00675-7.
2
The Impact of Local Control on Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Cancer: A Retrospective Analysis.局部控制对寡转移癌肝转移灶经钇-90 选择性体内放射治疗后总生存的影响:一项回顾性分析
Cancers (Basel). 2024 Jun 29;16(13):2401. doi: 10.3390/cancers16132401.
3
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.
Y90 放射性栓塞治疗经动脉栓塞治疗后的肝细胞癌患者的结果。
Curr Oncol. 2024 May 8;31(5):2650-2661. doi: 10.3390/curroncol31050200.
4
Interventional Radiology Locoregional Therapies for Intrahepatic Cholangiocarcinoma.肝内胆管癌的介入放射学局部治疗
Life (Basel). 2024 Feb 2;14(2):217. doi: 10.3390/life14020217.
5
Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.影响钇-90 放射性栓塞治疗经大量预处理的肝内胆管细胞癌患者结局的因素。
Abdom Radiol (NY). 2023 Jul;48(7):2434-2442. doi: 10.1007/s00261-023-03930-0. Epub 2023 May 5.
6
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with Y resin microspheres for chemo-refractory colorectal liver metastases.TAS-102(替氟尿苷和盐酸替匹嘧啶)联合 Y 树脂微球放射性栓塞治疗化疗耐药结直肠癌肝转移的 I 期前瞻性研究。
BMC Cancer. 2022 Dec 13;22(1):1307. doi: 10.1186/s12885-022-10401-0.
7
The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors.美国近距离放射治疗学会关于钇-90 微球放射性栓塞永久性植入近距离放射治疗肝脏肿瘤的共识声明。
Brachytherapy. 2022 Sep-Oct;21(5):569-591. doi: 10.1016/j.brachy.2022.04.004. Epub 2022 May 20.
8
A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study.一项前瞻性、多中心、开放性、单臂临床试验设计,旨在评估 Y 树脂微球治疗不可切除 HCC 的安全性和有效性:DOORwaY90 研究(动脉钇 90 治疗的客观缓解持续时间)。
BMC Gastroenterol. 2022 Mar 28;22(1):151. doi: 10.1186/s12876-022-02204-1.
9
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients.经动脉放射性栓塞治疗不可切除肝细胞癌:韩国患者的实际疗效与安全性分析
Cancers (Basel). 2022 Jan 13;14(2):385. doi: 10.3390/cancers14020385.
10
Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.经肝动脉放射栓塞治疗肝细胞癌后的治疗反应评估。
Abdom Radiol (NY). 2021 Aug;46(8):3596-3614. doi: 10.1007/s00261-021-03095-8. Epub 2021 Apr 28.